Acute Hepatic Porphyria (AHP) is a group of rare genetic liver disorders that can cause severe, life threatening attacks and long-term health issues that require monitoring. Treatment for AHP focuses ...
During the treatment phase, the effects of placebo or givosiran on the number and frequency of porphyria attacks, as well as on the levels of ALA and PBG, were measured prospectively in a blinded ...
An acute hepatic porphyria (AHP) episode is a medical emergency with severe symptoms like intense pain and seizures. Having a pre-arranged emergency plan is crucial for prompt treatment and to avoid ...
Acute hepatic porphyria (AHP) is a group of rare genetic disorders that affect the liver’s ability to produce heme, a vital component of blood, and can manifest with a variety of symptoms often ...
Acute intermittent porphyria (AIP) is an inborn error of metabolism inherited via a fully identified autosomal dominant gene. The porphyrias, a group of diseases ...
Congenital erythropoietic porphyria (CEP) is a rare autosomal recessive disorder characterised by a deficiency of uroporphyrinogen III synthase (UROS), a pivotal enzyme in the haem biosynthetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results